Now showing items 1-1 of 1

  • Cytochrome P450 mRNA profile in human breast cancer cell lines 

    Warasiha, Benjamart (The Robert Gordon University School of Pharmacy and Life Sciences, 2008-05)
    WARASIHA, B., KNOTT, R. and BOYLE, S., 2004. Investigation of the role of xenobiotic metabolising enzymes in breast cancer development. The Journal of Nutrition, 134 (12 Suppl), pp. 3525S
     
    WARASIHA, B., KNOTT, R. and MCFADYEN, M., 2007. Comparative analysis of Cytochrome P450 mRNA expression between human caucasian and Afro-Caribbean breast cancer cell lines. In:Proceedings of the National Cancer Research Institute (NCRI) Cancer conference. October 2007. Birmingham: ICC.
     
    WARASIHA, B., KNOTT, R. and MCFADYEN, M., 2007. Differential cytochrome P450 mRNA profile between non-invasive and invasive breast cancer phenotypes. In: Proceedings of National Cancer Research Institute (NCRI) cancer conference. October 2007. Birmingham: ICC.
     
    KAY, G., CAIRNS, D., MCCAUGHAN, B. and WARASIHA, B., 2007. The design, synthesis and biological evaluation of novel prodrugs for th treatment of cystinosis. In: Proceedings of the British Conference Pharmaceutical (BCP), September 2007. Manchester.
     
    KAY, G., WARASIHA, B., MELVILLE, M. and MINCHER, D. J., 2007. Design, synthesis and biological evaluation of novel DNA binding agents. In: Proceedings of the British Conference Pharmaceutical (BCP), September 2007. Manchester.
     
    WARASIHA, B., KNOTT, R. and MCFADYEN, M., 2006. Profile of cytochrome P450 mRNA expression in oestrogen positive and negative breast cancer cell lines. In: Proceedings of National Cancer Research Institute (NCRI) cancer conference, October 2006. Birmingham: ICC.
     
    Cytochrome P450 enzymes (P450s) are involved in cancer development and treatment due to their roles in the oxidative metabolism of various endogenous (e.g. oestrogen) and exogenous (e.g. tamoxifen) compounds. It is ...